214 related articles for article (PubMed ID: 32270202)
1. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
[TBL] [Abstract][Full Text] [Related]
2. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors.
Medica ACO; Whitcomb BW; Shliakhsitsava K; Dietz AC; Pinson K; Lam C; Romero SAD; Sluss P; Sammel MD; Su HI
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1002-e1013. PubMed ID: 33141175
[TBL] [Abstract][Full Text] [Related]
3. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
4. Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors.
Roberts SC; Seav SM; McDade TW; Dominick SA; Gorman JR; Whitcomb BW; Su HI
Hum Reprod; 2016 Jul; 31(7):1570-8. PubMed ID: 27170433
[TBL] [Abstract][Full Text] [Related]
5. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.
Cameron K; Sammel MD; Prewitt M; Gracia C
J Clin Endocrinol Metab; 2019 May; 104(5):1813-1822. PubMed ID: 30566616
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
[TBL] [Abstract][Full Text] [Related]
7. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
10. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study.
Brougham MF; Crofton PM; Johnson EJ; Evans N; Anderson RA; Wallace WH
J Clin Endocrinol Metab; 2012 Jun; 97(6):2059-67. PubMed ID: 22472563
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
[TBL] [Abstract][Full Text] [Related]
13. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
[TBL] [Abstract][Full Text] [Related]
14. Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy.
Hoyos-Martinez A; Scheurer ME; Allen-Rhoades W; Okcu MF; Horne VE
J Adolesc Young Adult Oncol; 2023 Dec; 12(6):828-834. PubMed ID: 36976803
[No Abstract] [Full Text] [Related]
15. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
17. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial stress and ovarian function in adolescent and young adult cancer survivors.
Kim J; Whitcomb BW; Kwan B; Zava D; Sluss PM; Dietz A; Shliakhtsitsava K; Romero SAD; Natarajan L; Su HI
Hum Reprod; 2021 Jan; 36(2):405-414. PubMed ID: 33279981
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.
Anderson RA; Su HI
Front Endocrinol (Lausanne); 2020; 11():574263. PubMed ID: 33117288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
